Advancements in Gout Treatment and CPPD Classification Challenges

This chapter explores recent advancements in gout treatment, focusing on the role of SGLT2 inhibitors for patients with gout and diabetes. It also addresses the complexities of diagnosing calcium pyrophosphate deposition disease and the importance of updated classification criteria for improved patient outcomes.